Latest Production Development News

ImpediMed Limited has reported record quarterly revenue and cash receipts for Q2 FY25, alongside significant growth in reimbursement coverage and a robust sales pipeline, signaling strong momentum in its digital health platform business.

Optiscan Imaging Ltd has secured a $1.775 million R&D tax refund for FY24, more than doubling last year’s amount thanks to expanded claims on overseas research. The boost will fund ongoing development of its cutting-edge confocal laser endomicroscopy technology.

Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.

ResMed Inc. posted a robust second quarter for fiscal year 2025, with revenue climbing 10% to $1.3 billion and operating profit soaring 52%, driven by strong demand for sleep and breathing health products and operational efficiencies.

WhiteHawk Limited reports solid Q4 2024 results with $718K revenue and a major $2.4 million contract renewal, while advancing new partnerships and managing costs amid a modest operational cash loss.

My Rewards International Limited reports steady progress on its B2B rewards platform and the soft launch of its Klevo MasterCard, while navigating ongoing ASX suspension and securing a $15 million financing facility.

Zelira Therapeutics has secured a fourth funding tranche of US$681,000, advancing its HOPE® Autism Spectrum Disorder FDA trial process and bringing total funding to US$3.25 million. The company is progressing clinical validation and product development, including the transformation of Zenivol® into a capsule formulation.

Cycliq Group Ltd reports a robust Q2 FY2025 with a 15% rise in cash receipts to $1.92 million and strategic leadership appointments aimed at accelerating growth.

Cycliq Group Limited reported a robust net operating cash flow of $964,000 for the December 2024 quarter, bolstered by government grants and disciplined cost management. The company ended the period with a healthy cash balance of $1.12 million, signaling improved liquidity.

Cape Range Ltd reports a robust 23% revenue increase in its Biztrak software business for the December 2024 quarter, alongside a 68% surge in cash receipts, while investing in strategic corporate initiatives to fuel future growth.

IXUP Limited reports strong sales momentum driven by its largest-ever contract with iGaming Ontario, alongside strategic cost reductions and a clear path to positive cash flow by late 2025.

InteliCare advances its AI-driven platform deployment across multiple Hardi Aged Care sites, while expanding its commercial pipeline and enhancing product capabilities.